Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance.
- NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_assertion description "[We speculate that CYP1B1 inhibition in endometrial carcinomas could be a useful therapeutic approach as it regulates several potential anticancer targets like cyclin E1, Skp2, and TRAIL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance.
- NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_assertion evidence source_evidence_literature NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance.
- NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_assertion SIO_000772 19690133 NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance.
- NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_assertion wasDerivedFrom befree-20150227 NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance.
- NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_assertion wasGeneratedBy ECO_0000203 NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP288289.RAR2uMlRmvTqHvF-wxwJ1nJUOczq-5mjiA-ilYRMZmvi0130_provenance.